KYNTRA BIO, INC. Net Cash Provided by (Used in) Continuing Operations
KYNTRA BIO, INC. (KYNB) reported Net Cash Provided by (Used in) Continuing Operations of $47.87 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2026-03-16
- KYNTRA BIO, INC. net cash provided by (used in) continuing operations for fiscal 2025 was $47.87M, a 5.17% decline from fiscal 2024.
- KYNTRA BIO, INC. net cash provided by (used in) continuing operations for fiscal 2024 was $50.48M, a 38.10% decline from fiscal 2023.
- KYNTRA BIO, INC. net cash provided by (used in) continuing operations for fiscal 2023 was $81.55M.
| Period end | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|
| 2025-12-31 | $47.87M 10-K · filed 2026-03-16 |
| 2024-12-31 | $50.48M 10-K · filed 2026-03-16 |
| 2023-12-31 | $81.55M 10-K · filed 2025-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |